Nivolumab
CA045-020
Phase 2 mab terminated
Quick answer
Nivolumab for Ependymoma is a Phase 2 program (mab) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nektar Therapeutics UK Limited
- Indication
- Ependymoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated